Atria Investments’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.17M | Buy |
17,672
+359
| +2% | +$118K | 0.06% | 364 |
|
|
2025
Q4 | $6.07M | Sell |
17,313
-1,360
| -7% | -$460K | 0.07% | 322 |
|
|
2025
Q3 | $6.03M | Sell |
18,673
-603
| -3% | -$188K | 0.07% | 327 |
|
|
2025
Q2 | $7.5M | Buy |
19,276
+3,703
| +24% | +$1.49M | 0.09% | 262 |
|
|
2025
Q1 | $6.77M | Buy |
15,573
+922
| +6% | +$370K | 0.09% | 269 |
|
|
2024
Q4 | $5.4M | Sell |
14,651
-4,897
| -25% | -$2.05M | 0.07% | 325 |
|
|
2024
Q3 | $10.2M | Sell |
19,548
-1,421
| -7% | -$759K | 0.13% | 181 |
|
|
2024
Q2 | $11.4M | Buy |
20,969
+1,071
| +5% | +$566K | 0.15% | 151 |
|
|
2024
Q1 | $10.3M | Buy |
19,898
+765
| +4% | +$380K | 0.14% | 167 |
|
|
2023
Q4 | $9.02M | Sell |
19,133
-568
| -3% | -$263K | 0.14% | 174 |
|
|
2023
Q3 | $8.58M | Buy |
19,701
+1,494
| +8% | +$678K | 0.15% | 155 |
|
|
2023
Q2 | $8.09M | Sell |
18,207
-613
| -3% | -$283K | 0.15% | 163 |
|
|
2023
Q1 | $8.65M | Buy |
18,820
+266
| +1% | +$127K | 0.16% | 153 |
|
|
2022
Q4 | $9.52M | Buy |
18,554
+841
| +5% | +$427K | 0.2% | 127 |
|
|
2022
Q3 | $8.05M | Buy |
17,713
+955
| +6% | +$457K | 0.18% | 136 |
|
|
2022
Q2 | $8.09M | Buy |
16,758
+143
| +0.9% | +$70.7K | 0.17% | 146 |
|
|
2022
Q1 | $8.16M | Buy |
16,615
+1,757
| +12% | +$803K | 0.14% | 171 |
|
|
2021
Q4 | $6.89M | Buy |
14,858
+374
| +3% | +$157K | 0.12% | 201 |
|
|
2021
Q3 | $5.4M | Buy |
14,484
+332
| +2% | +$126K | 0.1% | 227 |
|
|
2021
Q2 | $5.4M | Buy |
14,152
+560
| +4% | +$214K | 0.1% | 224 |
|
|
2021
Q1 | $4.88M | Buy |
13,592
+1,972
| +17% | +$634K | 0.11% | 215 |
|
|
2020
Q4 | $3.73M | Buy |
11,620
+774
| +7% | +$238K | 0.09% | 251 |
|
|
2020
Q3 | $2.91M | Buy |
10,846
+726
| +7% | +$195K | 0.09% | 250 |
|
|
2020
Q2 | $2.66M | Buy |
10,120
+1,650
| +19% | +$440K | 0.09% | 258 |
|
|
2020
Q1 | $1.92M | Sell |
8,470
-969
| -10% | -$264K | 0.15% | 135 |
|
|
2019
Q4 | $2.85M | Buy |
9,439
+2,124
| +29% | +$584K | 0.08% | 228 |
|
|
2019
Q3 | $1.76M | Sell |
7,315
-387
| -5% | -$106K | 0.06% | 263 |
|
|
2019
Q2 | $2.17M | Buy |
+7,702
| New | +$2.1M | 0.08% | 210 |
|
|
2019
Q1 | – | Sell |
-4,910
| Closed | -$1.29M | – | 957 |
|
|
2018
Q4 | $1.29M | Sell |
4,910
-913
| -16% | -$251K | 0.06% | 254 |
|
|
2018
Q3 | $1.6M | Buy |
5,823
+301
| +5% | +$78.1K | 0.06% | 287 |
|
|
2018
Q2 | $1.31M | Buy |
5,522
+301
| +6% | +$69.7K | 0.06% | 324 |
|
|
2018
Q1 | $1.15M | Buy |
5,221
+954
| +22% | +$224K | 0.06% | 325 |
|
|
2017
Q4 | $960K | Sell |
4,267
-327
| -7% | -$69.6K | 0.05% | 343 |
|
|
2017
Q3 | $872K | Sell |
4,594
-687
| -13% | -$131K | 0.05% | 340 |
|
|
2017
Q2 | $993K | Sell |
5,281
-640
| -11% | -$115K | 0.06% | 300 |
|
|
2017
Q1 | $979K | Sell |
5,921
-746
| -11% | -$119K | 0.06% | 264 |
|
|
2016
Q4 | $958K | Buy |
6,667
+932
| +16% | +$125K | 0.07% | 237 |
|
|
2016
Q3 | $719K | Buy |
5,735
+1,313
| +30% | +$170K | 0.07% | 248 |
|
|
2016
Q2 | $570K | Sell |
4,422
-53
| -1% | -$7.25K | 0.06% | 239 |
|
|
2016
Q1 | $622K | Buy |
4,475
+247
| +6% | +$33K | 0.07% | 208 |
|
|
2015
Q4 | $559K | Buy |
4,228
+1,070
| +34% | +$147K | 0.06% | 208 |
|
|
2015
Q3 | $442K | Sell |
3,158
-363
| -10% | -$54.6K | 0.06% | 208 |
|
|
2015
Q2 | $578K | Sell |
3,521
-381
| -10% | -$60.9K | 0.07% | 222 |
|
|
2015
Q1 | $603K | Buy |
+3,902
| New | +$556K | 0.07% | 215 |
|
|
2014
Q4 | – | Sell |
-6,723
| Closed | -$804K | – | 427 |
|
|
2014
Q3 | $804K | Buy |
6,723
+73
| +1% | +$8.37K | 0.08% | 210 |
|
|
2014
Q2 | $716K | Buy |
6,650
+22
| +0.3% | +$2.27K | 0.07% | 222 |
|
|
2014
Q1 | $660K | Buy |
6,628
+73
| +1% | +$6.6K | 0.07% | 241 |
|
|
2013
Q4 | $606K | Sell |
6,555
-1,147
| -15% | -$102K | 0.06% | 260 |
|
|
2013
Q3 | $644K | Buy |
7,702
+397
| +5% | +$34K | 0.07% | 234 |
|
|
2013
Q2 | $598K | Buy |
+7,305
| New | +$547K | 0.07% | 158 |
|
Other funds holding ELV
VCM
VPM
Atria Investments's ELV Position: Q1 2026 in Review
Atria Investments increased its Elevance Health (ELV) stake by 2.1% in Q1 2026, buying an estimated $118K and bringing the position to 17,672 shares worth $5.17M. The position accounts for 0.06% of the portfolio, ranked #364.
Atria Investments first reported a position in ELV in Q2 2013 and has held it in 50 quarters since. The position peaked at $11.4M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Atria Investments held 17,672 shares of Elevance Health worth $5.17M as of Q1 2026.
- Atria Investments bought 359 Elevance Health shares in Q1 2026, an estimated $118K.
- Elevance Health made up 0.06% of Atria Investments's portfolio in Q1 2026, its #364 holding.
- Atria Investments first reported a position in Elevance Health in Q2 2013 and has held it in 50 quarters since.
- Atria Investments's Elevance Health position peaked at $11.4M in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.